This Article  • Full text  • PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on ISI (7)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Topic Collections  • Neurogenetics  • Genetic Disorders  • Genetics, Other  • Alert me on articles by topic

Arch Neurol. 2001;58:1739-1741.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

A PARADIGM SHIFT in the conceptualization of neurogenetics occurred on June 26, 2000, when the initial sequencing of the human genome was announced by Francis Collins, Director of the Human Genome Project of the National Institutes of Health, and J. Craig Venter of Celera Genomics. The press conference for this momentous announcement was held at the White House and was sponsored jointly by then-President Bill Clinton and Prime Minister Tony Blair in London, linked by satellite. On February 15, 2001, the International Human Genome Sequencing Consortium (led by Collins), and on February 16, 2001, the Celera Genomics Group (led by Venter), published their respective initial sequences of the human genome.^{1, 2} Both groups reported that the number of protein-encoding transcripts, or genes, in the human genome is about 30 000—far less than previously predicted. DNA was sequenced from 5 individuals: 3 males and 2 females, including 1 of African, 1 of Chinese, . . . [Full Text of this Article]

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Translational Research on the Way to Effective Therapy for Alzheimer Disease
Rosenberg
Arch Gen Psychiatry 2005;62:1186-1192.
ABSTRACT | FULL TEXT  

Tales From the Neural Genome: The Lessons of Homozygous Porphyria
Wilson
Arch Neurol 2004;61:1650-1651.
FULL TEXT  

Experimental Neurotherapeutics: Leaps and Bounds
Shoulson
Arch Neurol 2002;59:689-691.
FULL TEXT